2-[4-(6-Benzyl-4,5-dimethylpyridazin-3-yl)-2-methyl-3,4,5,6-tetrahydro-2H-[1,2]bipyrazinyl-5-yl]-propan-2-ol
CAS: 1204975-42-7
Rif. 3D-FB167151
1g | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
Leq506 is a small molecule that inhibits tumor growth and metastasis. It binds to the ATP-binding site of the enzyme phosphatidylinositol-3-kinase, which is an important regulator of cell proliferation. Leq506 has been shown to inhibit tumor growth in animal models of carcinoma and medulloblastoma. Leq506 also has anti-cancer activity against solid tumors and cell lines derived from human carcinomas. This drug has been designed to specifically target cancer cells without affecting healthy cells.